Wang Yi, Bai Yunting, Ma Haoguang, Wang Shaolei
Department of Orthopaedics, People's Hospital of Mianzhu, Mianzhu 618200, Sichuan.
Department of Orthopaedics, The Fifth People's Hospital of Jinan, Jinan 250022.
Medicine (Baltimore). 2020 Aug 28;99(35):e22024. doi: 10.1097/MD.0000000000022024.
In recent years, the clinical efficacy of spinal fusion (SF) or total disc arthroplasty (TDA) in the treatment of the degenerative lumbar disc disease is still controversial. The objective of this retrospective clinical trial was to investigate whether TDA was superior to the SF in the complication rates and clinical outcome scores.
This retrospective research was based on the Strengthening the Reporting of Observational studies in Epidemiology checklist. Internal clinical data sets for 2014 to 2018 were acquired and consolidated with the approval of the Institutional Review Committee of Shaoxing Hospital of Zhejiang University. Inclusion criteria in this present research included: low back pain without or with the leg pain for more than one year; failure of conservative treatment planned for more than three months; age was 25 to 60 years old; followed up for at least one year. The main outcome measure was disability and pain measured via the Norwegian version of Oswestry disability index 2.0. The other clinical outcomes included Short-Form Health Survey, reoperations, duration of surgery, complications, hospital stay length, as well as the blood loss. The significance was set at 0.05 level with the confidence intervals of 95%. The software package of SPSS (version 21.0; SPSS Inc, Chicago, IL, USA) was applied for all the analyses of statistics.
The null hypothesis is that there is no significant difference in outcomes between TDA and SF in the treatment of degenerative lumbar disc disease.
This study protocol was registered in Research Registry (researchregistry5847).
近年来,脊柱融合术(SF)或全椎间盘置换术(TDA)治疗退变性腰椎间盘疾病的临床疗效仍存在争议。这项回顾性临床试验的目的是研究TDA在并发症发生率和临床结局评分方面是否优于SF。
这项回顾性研究基于流行病学观察性研究报告强化清单。获取了2014年至2018年的内部临床数据集,并在浙江大学绍兴医院机构审查委员会批准后进行了整合。本研究的纳入标准包括:下腰痛伴或不伴腿痛超过一年;计划进行的保守治疗失败超过三个月;年龄在25至60岁之间;随访至少一年。主要结局指标是通过挪威版奥斯威斯残疾指数2.0测量的残疾和疼痛。其他临床结局包括简短健康调查问卷、再次手术情况、手术时长、并发症、住院时间以及失血量。显著性设定为0.05水平,置信区间为95%。所有统计分析均使用SPSS软件包(版本21.0;SPSS公司,美国伊利诺伊州芝加哥)。
原假设是在治疗退变性腰椎间盘疾病方面,TDA和SF的结局无显著差异。
本研究方案已在研究注册库(researchregistry5847)注册。